High Persistence Rate at One Year- Follow-Up of Subcutaneous Vedolizumab at Standard Dose after Switching Endovenous Vedolizumab, Even in Those Previously Intensified: Results of a Spanish Multicentre Observational Study.
Gastroenterologia y hepatologia（2025）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined